Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): Clinical trial rationale and design
Demilade Adedinsewo(Jacksonville College), Rickey E. Carter(Mayo Clinic in Florida), Sabrina D. Phillips(Mayo Clinic), Francisco Lopez‐Jimenez(Mayo Clinic), Peter A. Noseworthy(WinnMed), Zachi I. Attia(Mayo Clinic in Arizona), Emily E. Sharpe(Mayo Clinic in Arizona), Andrea Carolina Morales-Lara(WinnMed), Mohamad H. Yamani(Jacksonville College), Patrick W. Johnson(Mayo Clinic in Florida), Yvonne Butler Tobah(Mayo Clinic in Arizona), Xiaoxi Yao(Mayo Clinic in Arizona), Erika J. Douglass(Mayo Clinic in Florida), Wendy T. Garzon-Siatoya(Jacksonville College), Jennifer Dugan(Mayo Clinic in Arizona), Carl H. Rose(Mayo Clinic in Arizona), Paul A. Friedman(Mayo Clinic)
Cited by 17
Related Papers
Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram
|Nature Medicine|2018|1.3k
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
|New England Journal of Medicine|2021|553
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
|Journal of Clinical Investigation|2020|485
Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
|Journal of the American Heart Association|2016|450
Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs
|Circulation Arrhythmia and Electrophysiology|2019|450